This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
According to national guidelines, mild persistent asthma is defined by a need for β-agonist treatment more than 2 days per week (but less than daily), asthma-related nighttime awakenings more than ...
A study of nearly 300 patients with mild persistent asthma found that inhaled steroids—long considered the gold standard for asthma treatment—were no more effective than placebo in nearly ...
Many patients with mild asthma take standard daily doses of inhaled corticosteroids indefinitely. Two new industry-supported, placebo-controlled, randomized trials - each with about 500 participants ...
According to a recent study presented at the American Thoracic Society International Conference in Dallas, Texas, and simultaneously published in the New England Journal of Medicine, nearly ...
A large international study led by a Hamilton researcher has found a patient-centric treatment that works for people with mild asthma. People with mild asthma are often prescribed a daily treatment ...
New research has shown that the millions of people who use corticosteroids prescribed daily to control mild asthma do no better than those who use them only when symptoms occur. The findings suggest a ...
Patients with very mild or well-controlled asthma can significantly improve day-to-day lung function if regularly treated with low dose inhaled corticosteroids (ICS), according to a new study ...
People with mild asthma are often prescribed a daily treatment regimen, but up to 80 per cent do not follow the routine, using inhalers only when they have an asthma attack. Now the researchers have ...
Children with mild asthma may use two inhalers – one steroid and the other a bronchodilator, when symptoms occur, a new study shows. A team of researchers at the Washington University School of ...
In a recent study published in the Respiratory Research journal, researchers in Hong Kong assessed the deterioration of asthma control in patients recovering from mild to moderate coronavirus disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results